7189819
MilliporeSigma™ Supelco™ Astec™ CHIROBIOTIC™ V Chiral HPLC Column, 5 μm Particle Size
Neutral molecules, amides, acids, esters and amines show considerable enantioselectivity on these vancomycin-based CSPs.
Manufacturer: Fischer Scientific
The price for this product is unavailable. Please request a quote
Particle Size
5 μm
Stationary Phase
Vancomycin
Matrix
Vancomycin Phase/High-Purity Silica Gel Particle Platform
Technique
Chiral HPLC
Pore Size
100 Å
Product Line
Astec CHIROBIOTIC
Phase
Chiral
Related Products
Description
- A wide variety of secondary and tertiary amines have been separated on the CHIROBIOTIC™ V in the polar ionic mode
- The CHIROBIOTIC™ V has demonstrated many of the separation characteristics of protein-based stationary phases, but with exceptional stability and much higher sample capacity
- Some chiral analytes have been resolved that have not been reported separated on any other chiral stationary phase
- CHIROBIOTIC™ V and V2 differ in their bonding chemistry the pore size of the support particle, giving them different selectivity and preparative capacity.
Compare Similar Items
Show Difference
Particle Size: 5 μm
Stationary Phase: Vancomycin
Matrix: Vancomycin Phase/High-Purity Silica Gel Particle Platform
Technique: Chiral HPLC
Pore Size: 100 Å
Product Line: Astec CHIROBIOTIC
Phase: Chiral
Particle Size:
5 μm
Stationary Phase:
Vancomycin
Matrix:
Vancomycin Phase/High-Purity Silica Gel Particle Platform
Technique:
Chiral HPLC
Pore Size:
100 Å
Product Line:
Astec CHIROBIOTIC
Phase:
Chiral
Particle Size: 2.7 μm
Stationary Phase: __
Matrix: __
Technique: __
Pore Size: 90 Å
Product Line: Ascentis
Phase: Reversed Phase
Particle Size:
2.7 μm
Stationary Phase:
__
Matrix:
__
Technique:
__
Pore Size:
90 Å
Product Line:
Ascentis
Phase:
Reversed Phase
Particle Size: 3 μm
Stationary Phase: C18 (octadecyl)
Matrix: C18 (octadecyl) Phase/Fused-Core Particle Platform
Technique: Fused-Core HPLC
Pore Size: 100 Å
Product Line: Ascentis
Phase: Reversed Phase
Particle Size:
3 μm
Stationary Phase:
C18 (octadecyl)
Matrix:
C18 (octadecyl) Phase/Fused-Core Particle Platform
Technique:
Fused-Core HPLC
Pore Size:
100 Å
Product Line:
Ascentis
Phase:
Reversed Phase
Particle Size: 3 μm
Stationary Phase: C4 (Butyl)
Matrix: C4 (Butyl) Phase
Technique: Chiral HPLC
Pore Size: 1000 Å
Product Line: ChromegaChiral
Phase: Chiral
Particle Size:
3 μm
Stationary Phase:
C4 (Butyl)
Matrix:
C4 (Butyl) Phase
Technique:
Chiral HPLC
Pore Size:
1000 Å
Product Line:
ChromegaChiral
Phase:
Chiral